Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.
暂无分享,去创建一个
R Peto | J. Danesh | R. Collins | R. Peto | P. Appleby | P Appleby | R Collins | J Danesh | John Danesh
[1] A. Döring,et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.
[2] J. Danesh,et al. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies , 1998, BMJ.
[3] A. Siegbahn,et al. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. , 1997, Circulation.
[4] W. Rutishauser,et al. C-reactive protein as a marker for acute coronary syndromes. , 1997, European heart journal.
[5] D. Ardissino,et al. C-reactive protein elevation and early outcome in patients with unstable angina pectoris. , 1997, The American journal of cardiology.
[6] E. Topol,et al. Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase. , 1997, The American journal of cardiology.
[7] M. Woodward,et al. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study , 1997, BMJ.
[8] A. Folsom,et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. , 1997, Circulation.
[9] J. Danesh,et al. Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.
[10] Murray Wm. Inflammation, aspirin, and the risk of cardiovascular disease. , 1997 .
[11] F. Niculescu,et al. Inflammation, aspirin, and the risk of cardiovascular disease. , 1997, The New England journal of medicine.
[12] S. Ogawa,et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. , 1997, Circulation.
[13] G. Assmann,et al. Coagulation factor VII and the risk of coronary heart disease in healthy men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[14] G. Frisoni,et al. Albumin as a predictor of mortality in elderly patients. , 1997, Journal of clinical epidemiology.
[15] P. Goldwasser,et al. Association of serum albumin and mortality risk. , 1997, Journal of clinical epidemiology.
[16] L H Kuller,et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[17] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[18] P. Elwood,et al. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. , 1997, American journal of epidemiology.
[19] S. Thompson,et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina , 1997, The Lancet.
[20] C. Visser,et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. , 1997, Circulation.
[21] E. Feskens,et al. Serum Albumin, Coronary Heart Disease Risk, and Mortality in an Elderly Cohort , 1997, Epidemiology.
[22] A. Rumley,et al. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study , 1997, British journal of haematology.
[23] A. Rumley,et al. Blood rheology and outcome in the West of Scotland Coronary Prevention Study , 1997 .
[24] P C Elwood,et al. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. , 1996, European heart journal.
[25] P. Hufnagl,et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. , 1996, Journal of cell science.
[26] L. Kuller,et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.
[27] R. Russell,et al. Use of albumin as a predictor of mortality in community dwelling and institutionalized elderly populations. , 1996, Journal of clinical epidemiology.
[28] G. Ciliberto,et al. Elevated levels of interleukin-6 in unstable angina. , 1996, Circulation.
[29] A. Pasternack,et al. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. , 1996, European heart journal.
[30] Y. Marcel,et al. Serum albumin is a significant intermediate in cholesterol transfer between cells and lipoproteins. , 1996, Biochemistry.
[31] J. Guralnik,et al. Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. , 1996, Journal of clinical epidemiology.
[32] D. Strachan,et al. C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.
[33] E. Feskens,et al. White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[34] D. Brunner,et al. Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[35] B. Kasiske,et al. Serum albumin and mortality after renal transplantation. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] D. Strachan,et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors , 1995, BMJ.
[37] M. Segal,et al. Relation of FEV1 and peripheral blood leukocyte count to total mortality. The Normative Aging Study. , 1995, American journal of epidemiology.
[38] S. Thompson,et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.
[39] A. Folsom. Epidemiology of fibrinogen. , 1995, European heart journal.
[40] A. Pezzano,et al. C-reactive protein and serum amyloid A protein in unstable angina. , 1995, The New England journal of medicine.
[41] A. Rebuzzi,et al. 973-113 Elevated C-Reactive Protein at Discharge and at Three Months After Waning of Symptoms in Unstable Angina is Associated with Recurrence of Instability During 12 Months Follow-up , 1995 .
[42] J. Sorkin,et al. Serum albumin level and physical disability as predictors of mortality in older persons. , 1994, JAMA.
[43] A. Rebuzzi,et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.
[44] J. Gauldie,et al. The acute phase response. , 1994, Immunology today.
[45] Serum albumin and mortality in the BUPA study. British United Provident Association. , 1994, International journal of epidemiology.
[46] J. González-Juanatey,et al. Leukocyte count as a predictor of the severity ischaemic heart disease as evaluated by coronary angiography. , 1993, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[47] T. Meade,et al. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study , 1993, The Lancet.
[48] G. Specchia,et al. Increased Expression of Neutrophil and Monocyte Adhesion Molecules in Unstable Coronary Artery Disease , 1993, Circulation.
[49] G. Vercellotti,et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor , 1993 .
[50] E. Ernst,et al. Fibrinogen as a Cardiovascular Risk Factor , 1993, Annals of Internal Medicine.
[51] J. Stamler,et al. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. , 1993, The Journal of clinical investigation.
[52] R. Gillum,et al. White blood cell count, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study. , 1993, American heart journal.
[53] P. Ducimetiere,et al. Monocyte count: a risk factor for coronary heart disease? , 1993, American journal of epidemiology.
[54] S. Akira,et al. Interleukin-6 in biology and medicine. , 1993, Advances in immunology.
[55] D. Cook,et al. Leukocyte count and risk of major coronary heart disease events. , 1992, American journal of epidemiology.
[56] J. Huttunen,et al. Leukocytes as a coronary risk factor in a dyslipidemic male population. , 1992, American heart journal.
[57] L. Welin,et al. Social network and activities in relation to mortality from cardiovascular diseases, cancer and other causes: a 12 year follow up of the study of men born in 1913 and 1923. , 1992, Journal of epidemiology and community health.
[58] K. Anderson,et al. White blood cell count and cardiovascular disease. Insights from the Framingham Study. , 1992, JAMA.
[59] E. Barrett-Connor,et al. Albumin levels as a predictor of mortality in the healthy elderly. , 1992, Journal of clinical epidemiology.
[60] M. Burr,et al. Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). , 1992, European heart journal.
[61] D. Cook,et al. The leukocyte count and risk of lung cancer , 1992, Cancer.
[62] R. Gillum,et al. Serum albumin, coronary heart disease, and death. , 1992, American heart journal.
[63] M. Chung,et al. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? , 1992, The American journal of medicine.
[64] M. Burr,et al. Influence of platelet size on outcome after myocardial infarction , 1991, The Lancet.
[65] L H Kuller,et al. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. , 1991, American journal of epidemiology.
[66] S. Yasumura,et al. Longitudinal changes of serum albumin in elderly people living in the community. , 1991, Age and ageing.
[67] P. Easterbrook,et al. Publication bias in clinical research , 1991, The Lancet.
[68] W. Thompson,et al. Atherosclerotic plaque growth: presence of stimulatory fibrin degradation products. , 1990, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[69] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.
[70] P. Ducimetiere,et al. Serum albumin and mortality , 1990, The Lancet.
[71] R J Glynn,et al. White blood cell count as a predictor of mortality: results over 18 years from the Normative Aging Study. , 1990, Journal of clinical epidemiology.
[72] P. Whincup,et al. ASSOCIATION BETWEEN SERUM ALBUMIN AND MORTALITY FROM CARDIOVASCULAR DISEASE, CANCER, AND OTHER CAUSES , 1989, The Lancet.
[73] P. Taylor,et al. Body iron stores and the risk of cancer. , 1988, The New England journal of medicine.
[74] C. Jackson,et al. MICROALBUMINURIA AS PREDICTOR OF VASCULAR DISEASE IN NON-DIABETIC SUBJECTS Islington Diabetes Survey , 1988, The Lancet.
[75] V. Nguyen. Fibrinogen and risk of cardiovascular disease: Kannel WB, Wolf PA, Castelli WP, et al JAMA 258: 1183–1186 Sep 1987 , 1988 .
[76] R. Cotran,et al. The pathogenesis of atherosclerosis: atherogenesis and inflammation. , 1988, Laboratory investigation; a journal of technical methods and pathology.
[77] M. J. Mitchinson,et al. MACROPHAGES AND ATHEROGENESIS , 1987, The Lancet.
[78] J. Dormandy,et al. Leukocytes and the risk of ischemic diseases. , 1987, JAMA.
[79] R. Stevens,et al. Iron-binding proteins and risk of cancer in Taiwan. , 1986, Journal of the National Cancer Institute.
[80] D. Petitti,et al. The leukocyte count: associations with intensity of smoking and persistence of effect after quitting. , 1986, American journal of epidemiology.
[81] M. C. Stone,et al. Plasma fibrinogen--a major coronary risk factor. , 1985, The Journal of the Royal College of General Practitioners.
[82] C. Forbes,et al. White Blood Cell Count and Haematocrit as Predictors of Coronary Recurrence after Myocardial Infarction , 1985, Thrombosis and Haemostasis.
[83] P. Ueland,et al. Radioenzymic determination of homocysteine in plasma and urine. , 1985, Clinical chemistry.
[84] P. Ducimetière,et al. La baisse du taux de la fraction albumine-alpha-1 globuline des protéines sériques, facteur de risque des cardiopathies ischémiques , 1985 .
[85] M. Pepys,et al. C-reactive protein: binding to lipids and lipoproteins. , 1985, International review of experimental pathology.
[86] H. Shibata,et al. [Relationship of serum albumin concentration to aging and survivorship in the community volunteers aged 70]. , 1984, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.
[87] L. Wilhelmsen,et al. Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.
[88] Jonathan Scott Friedlaender,et al. Iron-binding proteins, hepatitis B virus, and mortality in the Solomon Islands. , 1983, American journal of epidemiology.
[89] M. Pepys,et al. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. , 1983, Advances in immunology.
[90] R. Prentice,et al. Leukocyte counts and coronary heart disease in a Japanese cohort. , 1982, American journal of epidemiology.
[91] J. Kostis,et al. Association of recurrent myocardial infarction with hemostatic factors: a prospective study. , 1982, Chest.
[92] A. Maseri,et al. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. , 1982, British heart journal.
[93] J. Richard,et al. Leukocyte count, smoking, and myocardial infarction. , 1981, The New England journal of medicine.
[94] R. Ross,et al. The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.
[95] A. Siegelaub,et al. The leukocyte count as a predictor of myocardial infarction. , 1974, The New England journal of medicine.
[96] P. White,et al. The natural history of coronary heart disease , 1970 .